These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18414777)

  • 21. Influence of personality on behavioral response to cholecystokinin-tetrapeptide in patients with panic disorder.
    Koszycki D; Zacharko RM; Bradwejn J
    Psychiatry Res; 1996 May; 62(2):131-8. PubMed ID: 8771610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct panicogenic activity of sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder.
    Plag J; Gaudlitz K; Zschucke E; Yassouridis A; Pyrkosch L; Wittmann A; Holsboer F; Ströhle A
    Curr Pharm Des; 2012; 18(35):5619-26. PubMed ID: 22632477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecystokinin-4 and panic.
    Abelson JL; Nesse RM
    Arch Gen Psychiatry; 1990 Apr; 47(4):395. PubMed ID: 2322091
    [No Abstract]   [Full Text] [Related]  

  • 24. Anxiety sensitivity and panic attack symptomatology.
    Cox BJ; Endler NS; Swinson RP
    Behav Res Ther; 1995 Sep; 33(7):833-6. PubMed ID: 7677722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.
    Koszycki D; Zacharko RM; Le Mellédo JM; Bradwejn J
    Depress Anxiety; 1998; 8(1):1-7. PubMed ID: 9750972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-reports of panic attacks and manifest anxiety in adolescents.
    King NJ; Gullone E; Tonge BJ; Ollendick TH
    Behav Res Ther; 1993 Jan; 31(1):111-6. PubMed ID: 8417721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
    Zwanzger P; Eser D; Völkel N; Baghai TC; Möller HJ; Rupprecht R; Padberg F
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):285-9. PubMed ID: 16817979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperventilation and panic attacks in general hospital patients.
    Spinhoven P; Onstein EJ; Sterk PJ; Le Haen-Versteijnen D
    Gen Hosp Psychiatry; 1993 May; 15(3):148-54. PubMed ID: 8325495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males.
    Goettel M; Fuertig R; Mack SR; Just S; Sharma V; Wunder A; den Boer J
    CNS Drugs; 2023 Dec; 37(12):1099-1109. PubMed ID: 38019356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4.
    Eser D; Leicht G; Baghai T; Pogarell O; Schüle C; Karch S; Nothdurfter C; Rupprecht R; Mulert C
    J Psychiatr Res; 2009 Jan; 43(4):393-400. PubMed ID: 18534623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte cholecystokinin concentrations in panic disorder.
    Brambilla F; Bellodi L; Perna G; Garberi A; Panerai A; Sacerdote P
    Am J Psychiatry; 1993 Jul; 150(7):1111-3. PubMed ID: 8317587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.
    Demiralay C; Jahn H; Kellner M; Yassouridis A; Wiedemann K
    World J Biol Psychiatry; 2012 Oct; 13(7):526-34. PubMed ID: 22111662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.
    Maron E; Tõru I; Tasa G; Must A; Toover E; Lang A; Vasar V; Shlik J
    Neurosci Lett; 2008 Dec; 446(2-3):88-92. PubMed ID: 18832011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers.
    Benkelfat C; Bradwejn J; Meyer E; Ellenbogen M; Milot S; Gjedde A; Evans A
    Am J Psychiatry; 1995 Aug; 152(8):1180-4. PubMed ID: 7625467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder.
    Bradwejn J; Koszycki D; Couëtoux du Tertre A; van Megen H; den Boer J; Westenberg H
    Arch Gen Psychiatry; 1994 Jun; 51(6):486-93. PubMed ID: 8192551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased anxiety during anticipation of unpredictable but not predictable aversive stimuli as a psychophysiologic marker of panic disorder.
    Grillon C; Lissek S; Rabin S; McDowell D; Dvir S; Pine DS
    Am J Psychiatry; 2008 Jul; 165(7):898-904. PubMed ID: 18347001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder.
    Ströhle A; Kellner M; Holsboer F; Wiedemann K
    Am J Psychiatry; 2001 Sep; 158(9):1514-6. PubMed ID: 11532742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder.
    Bradwejn J; Koszycki D; Annable L; Couëtoux du Tertre A; Reines S; Karkanias C
    Biol Psychiatry; 1992 Nov; 32(10):903-12. PubMed ID: 1467375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
    Hinkelmann K; Yassouridis A; Mass R; Tenge H; Kellner M; Jahn H; Wiedemann K; Wolf K
    J Psychiatr Res; 2010 Dec; 44(16):1148-53. PubMed ID: 20451215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholecystokinin and Panic Disorder: Reflections on the History and Some Unsolved Questions.
    Rehfeld JF
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.